Digital care pathway with asynchronous nurse messaging for hypertension
Official title: Digital Care Pathway and Asynchronous Communication for Primary Care Patients With Uncontrolled Hypertension: a Cluster-Randomized Controlled Trial
Run by Wellbeing Services County of Pirkanmaa · NCT07812350 · Data updated 2026-11-12
We’re testing whether a digital care pathway plus non-real-time nurse messaging helps adults with high blood pressure and whether it’s worth the cost.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 74 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Wellbeing Services County of Pirkanmaa Academic / other |
| Locations | 6 sites (Akaa, Pirkanmaa and 5 other locations) |
| Status | Recruiting |
| Started | October 15, 2026 |
| Main results expected | March 2028 |
| Study ends | September 2028 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07812350 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with hypertension diagnosed for at least three months, an office BP of 140/90 mmHg or higher at baseline, smartphone access, ability to log in with strong electronic identification, and ability to measure home blood pressure.
✕Probably not a fit
Patients with secondary hypertension, very high office BP, kidney disease with eGFR <30, pregnancy, or other conditions as specified who may not benefit from this digital approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study will assess the effectiveness and cost-effectiveness of a digital care pathway (DCP) combined with asynchronous messaging to support hypertension management in primary care. It is a prospective, cluster-randomized trial across six primary care centers in Pirkanmaa, Finland, comparing usual care, usual care plus DCP, and usual care plus DCP with asynchronous nurse messaging. Participants will be followed for six months, with home blood pressure monitoring and periodic clinic assessments to gauge blood pressure control and resource use. Randomization occurs at the center level, and blinding is not feasible due to the nature of the intervention. A training induction will prepare clinicians to implement the digital pathway and communication tools.
Why it matters
Potential benefit: If successful, patients may achieve better blood pressure control and the approach could offer a cost-effective way to manage hypertension in primary care.
How similar studies have gone: Previous digital health interventions for hypertension have shown mixed but promising improvements in BP control; this study tests a combined digital pathway with asynchronous nurse support in a real-world primary care setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * a diagnosis of hypertension for at least 3 months * an office blood pressure of ≥140/90 mmHg at baseline * access to a smartphone and the ability to use strong electronic identification for application login * ability to measure home blood pressure * ability to take care of the personal medication Exclusion Criteria: * unwillingness to participate in the study * secondary hypertension or hypertensive crisis (office blood pressure \>200/130 mmHg) * atrial fibrillation * stage 4 or 5 chronic kidney disease (eGFR \<30 mL/min/1.73 m²) * a life expectancy of less than 1 year * pregnancy or breastfeeding * a clearly impaired ability to use the study interventions or participate in the study, as determined by a healthcare professional (e.g., insufficient Finnish language proficiency, dementia, psychiatric illness, or sensory impairments)
Where it's running
-
Akaa health and social services centre, The Wellbeing Services County of Pirkanmaa
Akaa, Pirkanmaa, Finland Recruiting -
Sastamala health and social services centre, The Wellbeing Services County of Pirkanmaa
Sastamala, Pirkanmaa, Finland Recruiting -
Hatanpää health and social services centre, The Wellbeing Services County of Pirkanmaa
Tampere, Pirkanmaa, Finland Recruiting -
Hervanta health and social services centre, The Wellbeing Services County of Pirkanmaa
Tampere, Pirkanmaa, Finland Recruiting -
Linnainmaa health and social services centre, The Wellbeing Services County of Pirkanmaa
Tampere, Pirkanmaa, Finland Recruiting -
Valkeakoski health and social services centre, The Wellbeing Services County of Pirkanmaa
Valkeakoski, Pirkanmaa, Finland Recruiting
Study contacts
- Principal investigator: Tuomas Koskela, Professor, Chief Physician — Faculty of Medicine and Health Technology, Tampere University, Finland. The Wellbeing Services County of Pirkanmaa, Finland
- Study coordinator: Teemu Ekola, MD
- Email: teemu.ekola@tuni.fi
- Phone: +358444863415
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.